| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $147,200 ) |
| | 2024 | 2024 | ANEUVAS TECHNOLOGIES INC | 2225 N GEMINI DR | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R41NS132732 | Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions | 000 | 2 | NIH | 6/12/2024 | $147,200 |
|
| Issue Date FY: 2023 ( Subtotal = $300,527 ) |
| | 2023 | 2023 | ANEUVAS TECHNOLOGIES INC | 2225 N GEMINI DR | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R41NS132732 | Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions | 000 | 1 | NIH | 6/28/2023 | $300,527 |
| | 2023 | 2020 | ANEUVAS TECHNOLOGIES INC | 2225 N GEMINI DR | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R42NS097069 | Application of PPODA-QT for embolization of aneurysms | 000 | 3 | NIH | 6/8/2023 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $718,443 ) |
| | 2020 | 2020 | ANEUVAS TECHNOLOGIES, INC. | 2225 N GEMINI RD | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R42NS097069 | Application of PPODA-QT for embolization of aneurysms | 000 | 3 | NIH | 8/6/2020 | $718,443 |
|
| Issue Date FY: 2019 ( Subtotal = $763,805 ) |
| | 2019 | 2019 | ANEUVAS TECHNOLOGIES, INC. | 2225 N GEMINI RD | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R42NS097069 | Application of PPODA-QT for embolization of aneurysms | 000 | 2 | NIH | 7/30/2019 | $763,805 |
| | 2019 | 2017 | ANEUVAS TECHNOLOGIES, INC. | 2225 N GEMINI RD | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R41NS097069 | Application of PPODA-QT for embolization of aneurysms | 000 | 1 | NIH | 1/6/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $220,109 ) |
| | 2017 | 2017 | ANEUVAS TECHNOLOGIES, INC. | 2225 N GEMINI RD | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R41NS097069 | Application of PPODA-QT for embolization of aneurysms | 001 | 1 | NIH | 2/3/2017 | $4,573 |
| | 2017 | 2017 | ANEUVAS TECHNOLOGIES, INC. | 2225 N GEMINI RD | FLAGSTAFF | AZ | 86001-1601 | COCONINO | USA | R41NS097069 | Application of PPODA-QT for embolization of aneurysms | 000 | 1 | NIH | 1/18/2017 | $215,536 |
|
|
